DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Krsnaa Diagnostics Limited (KRSNAA) share price today?

Krsnaa Diagnostics Limited (KRSNAA) is trading at ₹533.35 on the NSE, up 0.01% on the day. Source: DocStoX.

What is the PE ratio of Krsnaa Diagnostics Limited?

Krsnaa Diagnostics Limited has a price-to-earnings (PE) ratio of 17.0 in the Healthcare sector.

What is the market capitalisation of Krsnaa Diagnostics Limited?

Krsnaa Diagnostics Limited has a market capitalisation of approximately ₹1,730 crore.

Is Krsnaa Diagnostics Limited a profitable company?

Krsnaa Diagnostics Limited generates a return on equity of 10.3% with a net profit margin of 13.1%. That is a modest return on shareholder capital.

What is the 52-week high and low of KRSNAA?

Krsnaa Diagnostics Limited (KRSNAA) has traded between ₹515 and ₹843.35 over the past 52 weeks, against a current price of ₹533.35.

Does Krsnaa Diagnostics Limited pay a dividend?

Yes. Krsnaa Diagnostics Limited currently offers a dividend yield of 0.35%. Dividend payments depend on the board's declaration each year.

Krsnaa Diagnostics Limited

₹533.35▲ +0.05 (+0.01%)

KRSNAA·NSE·Healthcare

Market Cap

1729.95 Cr

PE Ratio

17.04

Volume

29,093

Day High - Low

534.85 - 526.00

52W High-Low

843.35 - 515.00

₹533.35▲ +0.05 (+0.01%)

Market Cap1729.95 Cr

PE Ratio17.04

Volume29,093

Day High - Low534.85 - 526.00

52W High-Low843.35 - 515.00

Krsnaa Diagnostics Limited (KRSNAA): company summary

The company's business is improving, with annual revenue rising 13.3% and annual net profit growing 22.2%.

Krsnaa Diagnostics Limited (KRSNAA) is a micro-cap Healthcare company valued at ₹1,730 crore operating in Healthcare Service Provider on the NSE and BSE.

Recent price move: Krsnaa Diagnostics Limited last traded at ₹533.35, modestly up 0.01% on the day.
Recent developments: 2026-08-14: The company reported a 22% rise in revenue for the quarter, indicating strong growth in its diagnostic services. 2026-09-28: The company announced plans to sell diagnostic equipment worth up to ₹120 crore as part of its capex expansion, which impacted its share price negatively.
Financial performance: The company's business is improving, with annual revenue rising 13.3% and annual net profit growing 22.2%. However, the latest quarter showed a decline in net profit, falling 17.2% compared to the same quarter a year earlier, while revenue rose 33.8%.
Valuation multiples: The stock trades at 17.0 times earnings, a discount to the Healthcare median of 32.0, 1.86 times book value. It yields 0.3%.
Things to watch: The stock is 34.6% below its 52-week high, indicating a significant pullback from recent levels. The latest quarter's net profit fell 17.2%, which could signal pressure on margins or cost management.
Where it stands: Krsnaa Diagnostics Ltd has shown strong revenue growth over the past year and three years, but its latest quarter's net profit declined. The stock is trading below its 52-week high, and the company's recent capex expansion announcement had a mixed impact on its share price.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

4.4/10

Weak

Fair Value

ROE

10.35%

Average

P/E

17.04x

Fair

Debt / Equity

0.55

Moderate

Industry

Healthcare

Healthcare Service Provider

Overall View

Mixed

Price performance

Day₹526.00

₹534.85

52W₹515.00

₹843.35

DocStoX take

Supported by risk (8.3), but held back by momentum (0.0). Risk looks strong at 8.3, but that is offset by momentum at 0.0 and growth at 2.3. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence

4.4

/10

Weak

Quality

Solid

ROE 10.3%

Valuation

Rich

P/E 17.0×

Growth

Flat

Revenue +14.3% 5Y CAGR

Risk

Low risk

D/E 0.55

Momentum

Weak

6% of 52-week range

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹533

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹1,730 Cr

52W High / Low

₹843 / ₹515

Dividend Yield

0.35%

Promoter Holding

27.11%

EPS (TTM)

₹31.30

Book Value

₹302.23

Key highlights

Profitable in all of the last 5 years
Profit shrinking 11% a year
Growth is weak (2.3/10)

1 Positive4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Healthcare Service Provider

Explore Krsnaa Diagnostics Limited’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Krsnaa Diagnostics Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Laurus Labs Limited Cipla Limited Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited Mankind Pharma Limited Lupin Limited Manipal Health Enterprises Limited

Compare Krsnaa Diagnostics Limited with peers

Krsnaa Diagnostics Limited vs Sun Pharmaceutical Industries Limited Krsnaa Diagnostics Limited vs Divi's Laboratories Limited Krsnaa Diagnostics Limited vs Torrent Pharmaceuticals Limited Krsnaa Diagnostics Limited vs Apollo Hospitals Enterprise Limited Krsnaa Diagnostics Limited vs Zydus Lifesciences Limited Krsnaa Diagnostics Limited vs Laurus Labs Limited

Related tools & concepts

Value Krsnaa Diagnostics Limited with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

KRSNAA newsLatest coverage & filings Open screenerFilter the whole market